Books

1. Ross S. Travels with Shubh: A Memoir of the MetaWorks Journey. iUniverse,        Bloomington, IN. 2009.
2. Ross S. Multiple paths in healthcare. In: User-Driven Healthcare and Narrative Medicine: Utilizing Collaborative Social Networks and Technologies.  IGI Pharma, Hershey PA. November 2010.

Journal Articles (last 10 years)

1. Marelli C, Gunnarsson C, Ross S, Haas S, Stroup D,  Cloud P, Clopton P, DeMaria AN. Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans. J Am Coll Cardiol 2011; 58: 530-537.
2. Ross S, Samuels E, Gairy K, Iqbal S, Badamgarav E, Siris E. A Meta-analysis of the risk of fracture with medication non-adherence in osteoporosis. Value in Health 2011; 14: 571-581.
3. Ross, S. A Lexicon for User Driven Healthcare. International Journal of User Driven Healthcare 2011; 1(1): 50-54.
4. Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid CH, Symmons D. Cancer risk with TNF inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 2010; 19; 1-11. DOI: 10.1002/pds.2046
5. Pacik P, Rizzo J, Fang H, Ross SD, Moore M, Gunnarsson C. Comparing Robot-assisted to conventional laparoscopic hysterectomy: impact on cost, surgery time, and length of stay. J Minim Invasive Gynecol 2010; 17: 730-738.
6. Ross SD. Results of a survey of an online physician community regarding use of electronic medical records in office practices. Journal of Medical Practice Management  2009; January/February: 1-3.
7. Ross SD. Trends in meta-analysis.  Drug Information Journal 2009; 43:171-17
8. Luo W, Nordstrom BL, Fraeman K,  Nordyke R,  Ranganathan G,  Linz HE, Winterkorn A, Stokes M, Ross SD, Knopf K. Adherence to Guidelines for Use of Erythropoiesis Stimulating Agents in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records. Clinical Therapeutics 2008; 30: 2423-2435.
9. Ross SD, Allen IE, Probst C, Sercus B, Crean S, Ranganathan G.  Efficacy and safety of erythropoiesis-stimulating proteins in myelodysplastic syndrome: a systematic review and meta-analysis. Oncologist 2007; 12: 1264-1273.
10. Fahrbach K, Sledge I, Cella K, Linz H, Ross SD. A comparison of the accuracy of two minimally invasive breast biopsy methods: a systematic literature review and meta-analysis. Archives of Obstetrics and Gynecology 2006; 274: 63-73.
11. Ross SD, Allen IE, Seaman C, Sercus B.  Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review and meta-analysis. Clinical Therapeutics 2006; 28: 801-831.
12. Ross S. Trends in the risks and benefits to patients with cancer in phase 1 clinical trials. [Letter] JAMA 2005; 293:795.
13. Frame D. Ross SD. Systematic review methods: Becoming less dependent on "the coffee queue" . [letter]  BMJ 2005. (http://bmj.bmjjournals.com/cgi/eletters/331/7524/1064
14. Ross SD, Estok R, Frame D, Stone L, Ludensky V, Levine C. Disability and Chronic Fatigue Syndrome: A focus on function. Arch Intern Med 2004; 164: 1098-1107.
15. Ross SD, Estok R, Chopra S, French J. Management of newly diagnosed patients with epilepsy: A systematic review of the literature. Am Fam Phys 2004; 70: 824-828.
16. Ross S, Estok RP, Armstrong K, Levine C. Should risk factors for breast cancer influence the evaluation of breast abrnomalities: A systematic review of the literature. Am Fam Phys 2004; 70: 35-37.
17. Klawansky S, Komaroff E, Cavanaugh PF, Mitchell DY, Gordon MJ, Connelly JE, and Ross SD. The relationship between age, renal function, and bone mineral density in the US population.  Osteoporosis International 2003; 14: 570-576.
18. Levine C. Estok R,  Fahrbach K, Ross SD. Diagnosis and Treatment of Parkinson's Disease: A Systematic Review of the Literature. Summary, Evidence Report/Technology Assessment: Number 57. (prepared by MetaWorks Inc. under Contract No. 290-97-0016) AHRQ Publication No.  03-E039, Rockville, MD.June 2003.
19. Ross SD Fahrbach K, Frame D, Scheye R, Connelly JE,  Glaspy J.  The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review. Clinical Therapeutics. 2003; 25:1786-1805.
20. Nalysnyk L, Fahrbach K, Reynolds MW, Zhao SZ, Ross S.  Adverse Events in Coronary Artery Bypass Graft (CABG) trials: A Systematic Review and Analysis.  Heart 2003; 89(7):767-72.
21. Levine C. Estok R, Stone L, Fahrbach K, Ross SD. Systematic review of the Current Literature Related to Disability and Chronic Fatigue Syndrome. Evidence Report/ Technology Assessment No. 66 (Prepared by MetaWorks Inc. under Contract No. 290-97-0016) AHRQ Publication No. 03-E007, Rockville MD. December 2002.
22. Edwards B, Silcocks P,  Ross SD. Pharmacoepidemiology. Chapter 2, of Pharmacovigilance: Effective Safety Surveillance Strategies. Scrip Reports April 2002.
23. Faich G.; Allen I.E.; Ross S.D.; Lefkowith J.B. Lack of association of celecoxib with an increased risk of thromboembolic events. J Amer Coll Card 2002; 39: 271.
24. Borden SP, Monroe MM, Kupelnick B, Connelly JE, Doyle D, Ross SD, and Allen IE.  A systematic review of interferon alpha in the treatment of non-Hodgkin’s lymphoma. J Immunotherapy 2001; 1: 58-65.
25. Ross SD. Drug related adverse events: A readers’ guide to assessing literature reviews and meta-analyses.  Archives of Internal Medicine 2001; 161: 1041-1046.
26. Chadbourne E. Zhang S, Gordon MJ, Ro EY, Ross SD. Clinical outcomes in reduction mammaplasty: A systematic review and meta-analysis of published studies. Mayo Clinic Proceedings 2001; 76:503-510.
27. Ross SD, Nalysnyk L, Zhang S, et al. Discontinuation of antihypertensive agents due to adverse events: a systematic review and meta-analysis. Pharmacotherapy 2001; 21 (8): 940-953.
28. Zilberberg MD, Levine C, Komaroff E, Guldin M, Gordon MJ, Ross SD. "Clinical uses of gamma-linolenic acid: A systematic review of the literature," In: Huang YS and Ziboh VA, eds. Gamma-linolenic acid: Recent advances in biotechnology and clinical applications. AOCS Press, Champaign, IL, 2001. pp 90-104.
29. Ross, S. Down with fat , dumb, and happy! bmj.com/cgi/eletters/322/7286/569#14318, 7 May 2001.
30. Allen IE, Ross, SD, Borden SP, Monroe M, Kupelnick B, Connelly J, Ozer H.  Meta-Analysis to Assess the Efficacy of Interferon-alpha in Patients with Follicular Non-Hodgkin’s Lymphoma. Journal of Immunotherapy 2001; 24(1):58-65.
31. Ross S, Estok R, Chopra S, French J. Management of Newly Diagnosed Patients with Epilepsy: A Systematic Review of the Literature. Evidence Report/Technology Assessment No.39. (Prepared by MetaWorks Inc. under Contract No. 290-97-0016.) AHRQ Publication No. 01-E038. Rockville, MD. February 2001.
32. Levine C, Armstrong k, Chopra S, Estok R, Zhang S, Ross S. Diagnosis and Management of Specific Breast Abnormalities. Evidence Report/Technology Assessment No.33. (Prepared by MetaWorks Inc. under Contract No. 290-97-0016.) AHRQ Publication No. 01-E046. Rockville, MD. April 2001.
33. Allen IE, Monroe M, Connelly J, Cintron R,  Ross SD. Impact of postmenopausal hormone replacement therapy on dental outcomes: Systematic review of the literature and pharmacoeconomic analysis. Managed Care Interface. 2000; 13:93-9.
34. Ross SD, Dong E, Gordon M, Connelly JE, Kvasz M, Iyengar M and Mujais SK. Meta-analysis of outcome studies in end-stage renal disease. Kidney International 2000; 57: S28- S38.
35. Kvasc M , Allen IE, Gordon MJ, Ro EY, Estok R, Olkin I, and Ross SD. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis.  Medscape General Medicine, April 2000.
36. Ross SD, Allen IE, Harrison KJ, Kvasz M, Connelly J, Sheinhait IA. Systematic Review of the Literature Regarding the Diagnosis of Sleep Apnea. Sleep 2000; 23: 519-532.
37. Ross SD, Allen IE, Harrison KJ, et al. Systematic review of the literature regarding the diagnosis of sleep apnea. ACP Journal Club. 2000 Mar-Apr; 132-69.
    

Meeting Abstracts (last 5 years)

1. Holt TA, Gunnarsson CL, Cload PA, Haas S, Ross SD. Under−Diagnosis and Suboptimal Management of Adult Diabetes Mellitus in the U.S.: An Analysis of Electronic Medical Records.  Diabetes (Suppl) A2387−PO. June 2011.
2. Marelli C, Gunnarsson C, Ross S, Stroup D, Haas S, Cloud P, Clopton P, DeMaria AN. Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans . American Heart Association Annual Meeting, November 2010.
3. Cload, P,  Ross S, Zyczynski T, Haas S, Gunnarsson C. Underuse of BMD measurements and bisphosphonate treatment in women over age 50 with osteoporosis in a nationally-representative EMR database. ISPOR Annual Meeting, May 2010.
4. Cload P, Ross S, Kallenbach L, Haas S, Gunnarsson C. Impact of a seminal study on practice patterns: statin use before and after the JUPITER study. ISPOR Annual Meeting, May 2010.
5. Samuels E, Siris E,  Iqbal U,  Gairy K, Badamgarav E,  Ross S.  Systematic Review of the Risk of Fracture with Medication Non-Adherence in Post Menopausal Osteoporotic (PMO) Women. American College of Rheumatology Annual Meeting, October 2009.
6. Cload P, Marelli C, Ross S, Zyczynski T, Haas S, Gunnarsson C. Using electronic medical records (EMRs) to assess anticoagulation status according to stroke risk in patients with atrial fibrillation in ambulatory care settings. ISPOR Annual European Congress, 2009.
7. Marelli C, Cload P, Ross S, Kallenbach L, Haas S, Gunnarsson C. Using electronic medical records to identify undiagnosed diabetes in primary care practices.  ISPOR Annual European Congress, 2009.
8. Gunnarsson C, Kotlarz H, Ross SD. Health Technology Assessment in Asian-Pacific Countries. ISPOR Asia-Pacific. September 2008
9. Ross SD, Frame D, Winterkorn A, Fahrbach K. Analyses from routine patient care settings for clinical research purposes. ISPOR May 2007.
10. Luo W, Nordstrom B, Ranganathan G, Linz H,  Stokes M, Ross M, Knopf K.  Adherence to guidelines for use of erythropoiesis stimulating proteins in patients with chemotherapy-induced anemia: Trends from Electronic Medical Records  ISPOR 2007.
11. Ross SD. Using electronic medical records for clinical effectiveness research. ISPOR May 2007.
12. Ross SD. Using electronic medical records for clinical  research. DIA June 2007.
13. Luo W, Nordstrom B, Ranganathan G, Fraeman K, Linz H,Stokes M, Knopf K, Ross S. Adherence to guidelines for use of erythropoiesis stimulating proteins in patients with chemotherapy-induced anemia: Trends from Electronic Medical Records. MASCC 2007.
14. Frame D, Ross S. Concordance of study objectives with efficacy findings in metastatic breast cancer (MBC) treatment trials. ASCO 2007.
15. Luo W, Nordstrom B, Ranganathan G, Linz H,  Stokes M, Ross M, Knopf K.  Adherence to guidelines for use of erythropoiesis stimulating proteins in patients with chemotherapy-induced anemia: Trends from Electronic Medical Records  ASCO 2007.
16. Almasio PL, Cavalletto L, Chemello L, Craxi A, Fahrbach K, Frame D, Ling CY, Mauss S, Poordad FF, Ross SD, Zein NN, Herrine S, Trepo C.  Predictors of SVR in genotype 1 patients with treatment-naïve chronic HCV treated with PEG-IFN alfa-2b vs. PEG-IFN alfa-2a + ribavirin: A hierarchical linear regression analysis of retrospective data from 6 clinic sites. Gastroenterology 130(4), A-842, 2006.
17. Ross, Fahrbach K, Estok R, Sledge I.  Bariatric surgery using Swedish Adjustable Gastric Band or LAP-BAND: An updated systematic review of the literature and meta-analysis. ASBS, May 2006.
18. Ross SD, Allen IE, Seaman C, Sercus B.  Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review and meta-analysis. MASCC, June 2006.
19. Frame D, Fahrbach K, Reynolds M, Ross SD.  Use of thresholds for safety reporting in clinical trials. ISPOR 2005.
20. Reynolds M & Ross SD. EBM in Drug Development Seminar, DIA June 2005.
21. Ross SD. Clinical Trials Registries and Results Databases. AMIA October 2005.
22. Almasio PL,  Cavalletto L,  Chemello L, Craxi A, Fahrbach K, Frame D, Ling CY, Mauss S, Poordad FF, Ross SD, Zein NN, Herrine S, Trepo C.  Efficacy of PEG-IFN alfa-2b vs. PEG-IFN alfa-2a + ribavirin regimens in treatment-naïve chronic HCV patients: A cumulative meta-analysis of retrospective data from 6 clinic sites. AASLD, November 2005.